List of Excipients in API clindamycin phosphate and tretinoin gel 1.2%/0.025%
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing clindamycin phosphate and tretinoin gel 1.2%/0.025%
Detailed excipient profiles for clindamycin phosphate and tretinoin gel 1.2%/0.025%
Excipient focus: ANHYDROUS CITRIC ACID
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants not containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LAURETH-4
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants containing LAURETH-4
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants not containing LAURETH-4
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TROMETHAMINE
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants not containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin gel 1.2%/0.025% drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch